Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent

NACompletedINTERVENTIONAL
Enrollment

1,435

Participants

Timeline

Start Date

October 21, 2016

Primary Completion Date

September 20, 2018

Study Completion Date

August 26, 2020

Conditions
Coronary Stenosis
Interventions
DEVICE

SUPRAFLEX

Percutaneous Coronary Intervention

DEVICE

XIENCE

Percutaneous Coronary Intervention

Trial Locations (23)

Unknown

Research Centre BG-004, Plovdiv

Research Centre BG-001, Sofia

Research Centre HU-002, Budapest

Research Centre HU-001, Szeged

Research Centre IT-001, Milan

Research Centre NL-007, Amsterdam

Research Centre NL-008, Breda

Research Centre NL-009, Eindhoven

Research Centre NL-002, Leeuwarden

Research Centre NL-003, Rotterdam

Research Centre PL-002, Chrzanów

Research Centre PL-005, Kędzierzyn-Koźle

Research Centre NL-009, Warsaw

Research Centre ES-003, Barcelona

Research Centre ES-005, Barcelona

Research Centre ES-012, Madrid

Research Centre ES-018, Vigo

Research Centre GB-021, Belfast

Research Centre GB-002, Cardiff

Research Centre GB-010, Cottingham

Research Centre GB-022, London

Research Centre GB-013, Newcastle upon Tyne

Research Centre GB-012, Stevenage

All Listed Sponsors
collaborator

Sahajanand Medical Technologies Limited

INDUSTRY

lead

ECRI bv

INDUSTRY

NCT02870140 - Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent | Biotech Hunter | Biotech Hunter